What is Adenosine Triphosphate (ATP)? The Energy Currency of Life

Life, in its myriad forms, relies on intricate biological processes that demand a constant supply of energy. Within the complex machinery of living organisms, adenosine triphosphate, or ATP, stands as the principal molecule for energy storage and transfer at the cellular level. Understanding “what is adenosine triphosphate” is fundamental to grasping the very essence of life’s energy dynamics.

At its core, ATP is a nucleoside triphosphate. Its structure is elegantly simple yet powerfully functional: a nitrogenous base called adenine, a five-carbon sugar known as ribose, and a chain of three phosphate groups linked in series. This seemingly modest molecule is often dubbed the “energy currency” of the cell, a testament to its crucial role in fueling cellular activities. The readily available energy in ATP resides in the bonds connecting the second and third phosphate groups. Beyond its energy-providing capabilities, the breakdown of ATP through hydrolysis plays diverse roles in cellular signaling and the synthesis of DNA and RNA, highlighting its multifaceted importance.

The continuous creation of ATP, known as ATP synthesis, is driven by energy derived from various catabolic pathways, including the well-known cellular respiration, beta-oxidation of fatty acids, and ketosis. Cellular respiration, occurring predominantly in the mitochondria, is a powerhouse of ATP production, generating approximately thirty-two ATP molecules for every molecule of glucose fully oxidized. Conversely, ATP is constantly consumed to power essential cellular functions such as active ion transport, muscle contraction, nerve impulse transmission, substrate phosphorylation in metabolic pathways, and the synthesis of new molecules. This relentless cycle of ATP production and consumption underscores the cell’s high energy demand. In fact, human cells hydrolyze an astounding 100 to 150 moles of ATP daily to sustain proper bodily functions. Let’s delve deeper into the remarkable world of ATP and explore its pivotal role as the cornerstone of cellular energy.

Image alt text: Chemical structure of Adenosine Triphosphate (ATP) showing adenine base, ribose sugar, and three phosphate groups.

ATP at the Cellular Level: The Energy Currency in Action

ATP’s suitability as the cell’s energy currency stems from the unique nature of its phosphate groups, linked by phosphoanhydride bonds. These bonds are inherently energy-rich due to the closely positioned electronegative phosphate groups, which exert repulsive forces on each other. This inherent instability translates into a significant amount of potential energy stored within these phosphate-phosphate bonds. Through metabolic processes, ATP undergoes hydrolysis, breaking down into adenosine diphosphate (ADP), or further to adenosine monophosphate (AMP), and releasing free inorganic phosphate groups. The hydrolysis of ATP to ADP is an energetically favorable reaction, releasing a substantial amount of Gibbs free energy, approximately -7.3 kcal/mol (or -30.5 kJ/mol).[1] This energy release is what fuels cellular work.

Given its constant consumption, ATP must be continuously replenished to maintain cellular function. The typical intracellular concentration of ATP is maintained within a narrow range, from 1 to 10 μM.[2] Sophisticated feedback mechanisms are in place to ensure a stable ATP pool within the cell. A key regulatory point is the enzyme ATP synthase itself, whose activity is tightly controlled. For instance, when ATP levels are high, ATP acts as an inhibitor of key enzymes in glycolysis, such as phosphofructokinase-1 (PFK1) and pyruvate kinase. This negative feedback loop effectively slows down glucose breakdown, the primary pathway for ATP generation, when sufficient ATP is already available.

Conversely, when cellular energy demand is high and ATP levels drop, ADP and AMP act as activators of PFK1 and pyruvate kinase. This positive feedback mechanism accelerates glycolysis, promoting ATP synthesis to meet the increased energy needs. The regulation of ATP synthesis is a complex and finely tuned process, varying across different tissues and physiological conditions. For example, in the heart, novel research has uncovered “mitochondrial flashes,” brief, ten-second bursts of activity that can transiently disrupt ATP production. During these flashes, mitochondria release reactive oxygen species, temporarily pausing ATP synthesis. Interestingly, the frequency of mitochondrial flashes appears to be inversely related to energy demand in heart muscle cells. When energy demand is low and the heart cells have ample building blocks for ATP production, mitochondrial flashes occur more frequently, effectively dampening ATP synthesis. Conversely, during periods of high energy demand, such as rapid heart contractions, mitochondrial flashes are less frequent, allowing for sustained ATP production.[3] This intricate regulation ensures that ATP supply is precisely matched to the heart’s ever-changing energy requirements.

Function: The Multifaceted Roles of ATP in Cellular Processes

The energy liberated by ATP hydrolysis powers a vast array of essential processes within organisms and cells. These functions extend far beyond simple energy provision, encompassing crucial roles in intracellular signaling, DNA and RNA synthesis, purinergic signaling, synaptic transmission in the nervous system, active transport of molecules across cell membranes, and muscle contraction. While this list is not exhaustive, it highlights some of the most vital roles ATP plays in maintaining life.

ATP in Intracellular Signaling: A Key Signaling Molecule

Signal transduction pathways, the intricate communication networks within cells, are heavily reliant on ATP. ATP serves as a primary substrate for kinases, a large and diverse family of enzymes that are among the most numerous ATP-binding proteins in the cell. Kinases catalyze the transfer of a phosphate group from ATP to a protein, a process known as phosphorylation. This phosphorylation event can act as a molecular switch, activating or inactivating proteins and triggering signaling cascades that ultimately modulate a wide range of intracellular pathways.[4] Kinase activity is fundamental to virtually all aspects of cellular life and, therefore, must be precisely regulated. The magnesium ion (Mg2+) plays a critical role in regulating kinase activity.[5] Within the cell, magnesium ions typically exist in a complex with ATP, binding to the phosphate oxygen centers. This Mg-ATP complex is the preferred substrate for most kinases, influencing their catalytic efficiency and specificity.

Beyond its role as a phosphate donor for kinases, ATP can also function as a ubiquitous trigger for the release of intracellular messengers.[6] These messengers encompass a diverse group of signaling molecules, including hormones, various enzymes, lipid mediators, neurotransmitters, nitric oxide, growth factors, and reactive oxygen species.[6] For instance, ATP serves as a substrate for adenylate cyclase, an enzyme crucial in G-protein coupled receptor (GPCR) signaling pathways. Upon activation of adenylate cyclase by a GPCR, it converts ATP into cyclic AMP (cAMP), a critical second messenger molecule. cAMP, in turn, plays a central role in signaling the release of calcium ions from intracellular stores.[7] cAMP also participates in numerous other cellular processes, acting as a secondary messenger in hormone signaling cascades, activating protein kinases (such as protein kinase A), and regulating the function of ion channels.

DNA and RNA Synthesis: Building Blocks of Genetic Information

The synthesis of DNA and RNA, the molecules that carry and express our genetic information, critically depends on ATP. In RNA synthesis, ATP is one of the four ribonucleotide triphosphate monomers (along with GTP, CTP, and UTP) that are essential building blocks for constructing RNA molecules. DNA synthesis employs a similar mechanism, but with a slight modification. In DNA synthesis, ATP is first converted into deoxyadenosine triphosphate (dATP) by removing an oxygen atom from the ribose sugar, forming a deoxyribonucleotide. dATP, along with dGTP, dCTP, and dTTP, then serves as a precursor for DNA strand elongation.[8] Thus, ATP is not only an energy source but also a direct structural component of these fundamental genetic molecules.

Purinergic Signaling: Extracellular Communication with ATP

Purinergic signaling represents a fascinating mode of intercellular communication where ATP, acting outside the cell, serves as a signaling molecule. This form of extracellular paracrine signaling is mediated by purine nucleotides, most notably ATP, and adenosine. In purinergic signaling, ATP is released from cells and interacts with purinergic receptors located on neighboring cells. Activation of these receptors transduces signals across the cell membrane, triggering intracellular responses that regulate a wide range of physiological processes. ATP release from cells is often mediated by vesicular stores and regulated by intracellular signaling pathways, including IP3 and other exocytotic regulatory mechanisms. Intriguingly, ATP is often co-stored and co-released with classical neurotransmitters from neurons, further supporting its role as a key mediator of neurotransmission in both sympathetic and parasympathetic nerves. Purinergic signaling, mediated by ATP, elicits diverse physiological responses, including the control of autonomic functions (such as heart rate and digestion), interactions between neurons and glial cells in the brain, pain perception, and the regulation of blood vessel tone.[9, 10, 11, 12]

Neurotransmission: Powering the Nervous System

The brain, the command center of the body, is a remarkably energy-intensive organ, consuming approximately twenty-five percent of the body’s total energy budget, despite representing only about 2% of the body’s mass.[13] A significant portion of this energy expenditure is dedicated to maintaining the proper ion concentrations across neuronal membranes, essential for neuronal signaling and synaptic transmission.[14] Synaptic transmission, the process of communication between neurons, is a particularly energy-demanding process. At the presynaptic terminal, ATP is required for multiple steps, including establishing the ion gradients necessary for loading neurotransmitters into synaptic vesicles and for priming these vesicles for subsequent release through exocytosis.[14]

Neuronal signaling itself relies on the generation and propagation of action potentials, electrical signals that travel along nerve fibers. Upon reaching the presynaptic terminal, an action potential triggers the release of neurotransmitter-filled vesicles. Crucially, after each action potential, ATP is essential for restoring the ion concentrations within the axon to their resting state, enabling the neuron to fire another signal. This restoration is primarily achieved through the action of the sodium-potassium pump (Na+/K+ ATPase), an active transporter that uses ATP hydrolysis to pump sodium ions out of the cell and potassium ions back into the cell, both against their respective concentration gradients. For every molecule of ATP hydrolyzed, the Na+/K+ ATPase pumps three sodium ions out and two potassium ions in, re-establishing the electrochemical gradients necessary for neuronal excitability.

The energy cost of action potential propagation is substantial. It is estimated that approximately one billion sodium ions are required to propagate a single action potential along an axon. Consequently, neurons must hydrolyze nearly one billion ATP molecules to restore the sodium and potassium ion concentrations after each depolarization event.[13] Excitatory synapses, which utilize glutamate as their primary neurotransmitter, are particularly abundant in the gray matter of the brain. Vesicles containing glutamate are released into the synaptic cleft, activating postsynaptic excitatory glutamatergic receptors and transmitting the neuronal signal. Loading glutamate into these vesicles requires significant amounts of ATP, as each vesicle can store nearly four thousand glutamate molecules.[13] Sustaining glutamatergic neurotransmission demands considerable energy expenditure, not only for vesicle release and driving postsynaptic processes but also for recycling the vesicles and any leftover glutamate in the synaptic cleft.[13] To meet this high energy demand, mitochondria, the cellular power plants, are often strategically located in close proximity to glutamatergic vesicles, ensuring a readily available ATP supply.[15]

ATP in Muscle Contraction: Powering Movement

Muscle contraction, a fundamental process for movement and bodily functions, is absolutely dependent on ATP. ATP plays three primary roles in the intricate molecular mechanisms of muscle contraction. First, ATP hydrolysis provides the energy for the cyclic interaction of myosin and actin filaments, the molecular basis of muscle force generation. This cycle involves the binding of ATP to myosin, which leads to the detachment of myosin from actin. ATP is then hydrolyzed to ADP and inorganic phosphate, causing a conformational change in myosin that “cocks” the myosin head. The myosin head then re-attaches to actin, and the release of ADP and inorganic phosphate triggers the “power stroke,” pulling the actin filament past the myosin filament and generating force. This cycle repeats as long as ATP and calcium are available.

Second, ATP is essential for the active transport of calcium ions from the cytoplasm (myoplasm) back into the sarcoplasmic reticulum, a specialized intracellular calcium store within muscle cells. This calcium pumping, mediated by the sarcoplasmic reticulum Ca2+-ATPase (SERCA pump), occurs against a steep concentration gradient and requires ATP hydrolysis. The removal of calcium from the cytoplasm is crucial for muscle relaxation. Third, ATP is also required for maintaining the sodium and potassium ion gradients across the sarcolemma (muscle cell membrane) through the Na+/K+ ATPase, similar to its role in neurons. These ion gradients are essential for generating action potentials in muscle cells, which trigger the release of calcium ions from the sarcoplasmic reticulum and initiate muscle contraction. Thus, ATP hydrolysis directly drives each of these critical steps in the muscle contraction-relaxation cycle.[16]

Image alt text: Diagram illustrating the sarcomere structure and the mechanism of muscle contraction involving actin and myosin filaments.

Mechanism: Pathways of ATP Synthesis

The body employs a variety of metabolic pathways to generate ATP, adapting to different metabolic conditions and fuel sources. ATP production can occur both in the presence of oxygen (aerobic respiration) and in its absence (anaerobic respiration). Aerobic pathways include cellular respiration, beta-oxidation of fatty acids, and ketosis, while anaerobic respiration, such as lactic acid fermentation, provides ATP when oxygen is limited.

Cellular Respiration: The Primary ATP Generator

Cellular respiration is the central metabolic pathway for ATP production in most organisms. It involves the complete oxidation of glucose, a simple sugar, to carbon dioxide and water, capturing the released energy in the form of ATP. Cellular respiration can be divided into three main stages: glycolysis, the citric acid cycle (also known as the Krebs cycle), and oxidative phosphorylation.

Glycolysis, the first stage, occurs in the cytoplasm and involves the breakdown of one molecule of glucose into two molecules of pyruvate. This process generates a small net gain of ATP, specifically two ATP molecules per glucose molecule, through substrate-level phosphorylation catalyzed by the enzymes phosphoglycerate kinase and pyruvate kinase. Glycolysis also produces two molecules of NADH, a reduced electron carrier molecule that will be used in later stages for further ATP production.

The pyruvate molecules generated in glycolysis then enter the mitochondria, the cell’s powerhouses, where they are further processed. The pyruvate dehydrogenase complex oxidizes pyruvate to acetyl-CoA, a two-carbon molecule that enters the citric acid cycle. The citric acid cycle, occurring in the mitochondrial matrix, completes the oxidation of glucose. In each turn of the cycle, acetyl-CoA is completely oxidized to carbon dioxide, generating one molecule of ATP (or GTP, which is energetically equivalent to ATP) through substrate-level phosphorylation, three molecules of NADH, and one molecule of FADH2, another reduced electron carrier.

The NADH and FADH2 molecules produced in glycolysis and the citric acid cycle are crucial for the final stage of cellular respiration, oxidative phosphorylation. This process takes place in the inner mitochondrial membrane and involves the electron transport chain and ATP synthase. The electron transport chain is a series of protein complexes that sequentially transfer electrons from NADH and FADH2 to oxygen, the final electron acceptor. As electrons move through the chain, protons (H+) are pumped from the mitochondrial matrix into the intermembrane space, creating an electrochemical gradient across the inner mitochondrial membrane. This proton gradient represents stored potential energy. ATP synthase is an enzyme complex that harnesses the energy stored in the proton gradient to synthesize ATP. As protons flow back down their electrochemical gradient, from the intermembrane space into the mitochondrial matrix, through ATP synthase, the enzyme rotates and catalyzes the phosphorylation of ADP to ATP. The amount of ATP produced per molecule of glucose varies slightly depending on the efficiency of the electron transport chain, but it is generally estimated that approximately 2.5 ATP molecules are generated per NADH molecule and 1.5 ATP molecules per FADH2 molecule that enter oxidative phosphorylation.[17] Overall, cellular respiration yields a substantial amount of ATP, typically around 32 ATP molecules per molecule of glucose fully oxidized.

Beta-Oxidation: ATP from Fatty Acids

Beta-oxidation is a metabolic pathway that allows cells to generate ATP from fatty acids, an important energy storage form in the body. During beta-oxidation, fatty acid chains are progressively shortened by two carbon atoms at a time, yielding acetyl-CoA molecules. Each cycle of beta-oxidation produces one molecule of acetyl-CoA, which can enter the citric acid cycle for further ATP production, as well as one molecule of NADH and one molecule of FADH2. These electron carriers then feed into the electron transport chain, contributing to ATP synthesis through oxidative phosphorylation.[18] Beta-oxidation is particularly important in tissues like heart and skeletal muscle, which can utilize fatty acids as a major fuel source, especially during prolonged exercise or fasting.

Ketosis: ATP from Ketone Bodies

Ketosis is a metabolic state that occurs when glucose availability is limited, such as during prolonged fasting or in individuals with uncontrolled diabetes. In ketosis, the liver produces ketone bodies from fatty acids. Ketone bodies, such as acetoacetate, beta-hydroxybutyrate, and acetone, can be used as an alternative fuel source by many tissues, including the brain, heart, and muscle. Ketone body catabolism, primarily in mitochondria, generates ATP. For example, the oxidation of one molecule of acetoacetate yields approximately 22 ATP molecules and 2 GTP molecules (equivalent to ATP).[19] Ketosis provides a mechanism for the body to sustain energy production when glucose supply is insufficient.

Anaerobic Respiration: ATP in the Absence of Oxygen

When oxygen is scarce or unavailable, such as during intense muscle activity or in certain tissues with limited blood supply, cells can resort to anaerobic respiration to produce ATP. Under anaerobic conditions, the electron transport chain, which requires oxygen as the final electron acceptor, cannot function. This leads to a buildup of NADH molecules, as NADH cannot be effectively re-oxidized to NAD+. The accumulation of NADH inhibits key enzymes in glycolysis, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), slowing down glucose consumption. To maintain glycolysis and ATP production under anaerobic conditions, cells utilize lactic acid fermentation. In lactic acid fermentation, pyruvate, the end product of glycolysis, is reduced to lactate by the enzyme lactate dehydrogenase. This reaction simultaneously oxidizes NADH back to NAD+, regenerating the NAD+ required for glycolysis to continue. Lactic acid fermentation allows glycolysis to proceed even in the absence of oxygen, but it is much less efficient than aerobic respiration, producing only a net of two ATP molecules per molecule of glucose.

Related Testing: Measuring ATP Levels

Quantifying intracellular ATP levels is crucial for understanding cellular energy metabolism and function. Several methods are available for measuring ATP, but a widely accepted and sensitive technique relies on the firefly luciferase enzyme.[20] Firefly luciferase catalyzes the oxidation of luciferin, a light-emitting molecule, in a reaction that is ATP-dependent. This reaction produces bioluminescence, the emission of light from a biological system. The intensity of the emitted light is directly proportional to the concentration of ATP in the sample. By measuring the bioluminescence using a luminometer, researchers can accurately determine intracellular ATP levels. This luciferase-based assay is highly sensitive and can be used to measure ATP in various biological samples, from cell extracts to tissue samples.

Clinical Significance: Therapeutic Applications of ATP

Beyond its fundamental role in cellular energy, ATP and its related compounds have shown promising clinical applications, particularly in pain management, anesthesia, and cardiovascular conditions.

ATP’s Role in Pain Control: Alleviating Perioperative Pain

Clinical studies have demonstrated that ATP administration can effectively reduce acute perioperative pain.[21] In these studies, patients received intravenous infusions of ATP. The administered adenosine, derived from ATP breakdown, is believed to act on A1 adenosine receptors, initiating a signaling cascade that ultimately contributes to pain relief, particularly in inflammatory pain conditions. Research has indicated that adenosine compounds, when administered at moderate doses, can effectively decrease allodynia (pain response to a non-painful stimulus) and hyperalgesia (exaggerated pain response to a painful stimulus).[21] Activation of A1 adenosine receptors offers a potential therapeutic strategy for pain intervention, characterized by a slow onset of action but a long duration of effect, potentially lasting for weeks in some cases.[21]

Anesthesia: Enhancing Anesthetic Outcomes

ATP supplementation has also shown potential benefits in the context of anesthesia. Evidence suggests that low doses of adenosine can reduce neuropathic pain, ischemic pain, and hyperalgesia to a level comparable to morphine, a commonly used opioid analgesic.[22] Furthermore, adenosine administration has been associated with decreased postoperative opioid usage, suggesting a potential long-lasting activation of A1 adenosine receptors that contributes to sustained pain relief. These findings suggest that adenosine and ATP-based therapies could play a role in improving anesthetic outcomes and reducing reliance on opioid analgesics, which have significant side effects and risks of addiction.

Cardiology and Surgery: Cardiovascular Applications

ATP has demonstrated therapeutic potential in cardiovascular conditions. It has been shown to be a safe and effective pulmonary vasodilator in patients suffering from pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs.[22] Similarly, adenosine and ATP can be employed during surgical procedures to induce controlled hypotension in patients when reduced blood pressure is desired to minimize bleeding or improve surgical field visibility.[22] These cardiovascular applications highlight the diverse clinical utility of ATP and adenosine beyond their fundamental role in cellular energy metabolism.

Review Questions

1. Describe the structure of adenosine triphosphate (ATP).
2. Explain why ATP is referred to as the “energy currency” of the cell.
3. Outline the major cellular processes that require ATP.
4. Describe the main pathways of ATP synthesis in cells.
5. How is ATP production regulated at the cellular level?
6. Discuss the clinical significance of ATP and its potential therapeutic applications.

References

1. Meurer F, Do HT, Sadowski G, Held C. Standard Gibbs energy of metabolic reactions: II. Glucose-6-phosphatase reaction and ATP hydrolysis. Biophys Chem. 2017 Apr;223:30-38. [PubMed: 28282626]
2. Beis I, Newsholme EA. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J. 1975 Oct;152(1):23-32. [PMC free article: PMC1172435] [PubMed: 1212224]
3. Wang X, Zhang X, Wu D, Huang Z, Hou T, Jian C, Yu P, Lu F, Zhang R, Sun T, Li J, Qi W, Wang Y, Gao F, Cheng H. Mitochondrial flashes regulate ATP homeostasis in the heart. Elife. 2017 Jul 10;6 [PMC free article: PMC5503511] [PubMed: 28692422]
4. Mishra NS, Tuteja R, Tuteja N. Signaling through MAP kinase networks in plants. Arch Biochem Biophys. 2006 Aug 01;452(1):55-68. [PubMed: 16806044]
5. Lin X, Ayrapetov MK, Sun G. Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator. BMC Biochem. 2005 Nov 23;6:25. [PMC free article: PMC1316873] [PubMed: 16305747]
6. Zimmermann H. Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release. Purinergic Signal. 2016 Mar;12(1):25-57. [PMC free article: PMC4749530] [PubMed: 26545760]
7. Kamenetsky M, Middelhaufe S, Bank EM, Levin LR, Buck J, Steegborn C. Molecular details of cAMP generation in mammalian cells: a tale of two systems. J Mol Biol. 2006 Sep 29;362(4):623-39. [PMC free article: PMC3662476] [PubMed: 16934836]
8. Joyce CM, Steitz TA. Polymerase structures and function: variations on a theme? J Bacteriol. 1995 Nov;177(22):6321-9. [PMC free article: PMC177480] [PubMed: 7592405]
9. Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, Pinton P. ATP synthesis and storage. Purinergic Signal. 2012 Sep;8(3):343-57. [PMC free article: PMC3360099] [PubMed: 22528680]
10. Cárdenas C, Miller RA, Smith I, Bui T, Molgó J, Müller M, Vais H, Cheung KH, Yang J, Parker I, Thompson CB, Birnbaum MJ, Hallows KR, Foskett JK. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell. 2010 Jul 23;142(2):270-83. [PMC free article: PMC2911450] [PubMed: 20655468]
11. Pablo Huidobro-Toro J, Verónica Donoso M. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions. Eur J Pharmacol. 2004 Oct 01;500(1-3):27-35. [PubMed: 15464018]
12. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C. Storage and release of ATP from astrocytes in culture. J Biol Chem. 2003 Jan 10;278(2):1354-62. [PubMed: 12414798]
13. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001 Oct;21(10):1133-45. [PubMed: 11598490]
14. Harris JJ, Jolivet R, Attwell D. Synaptic energy use and supply. Neuron. 2012 Sep 06;75(5):762-77. [PubMed: 22958818]
15. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989 Mar;12(3):94-101. [PubMed: 2469224]
16. Barclay CJ. Energetics of contraction. Compr Physiol. 2015 Apr;5(2):961-95. [PubMed: 25880520]
17. Rich PR. The molecular machinery of Keilin’s respiratory chain. Biochem Soc Trans. 2003 Dec;31(Pt 6):1095-105. [PubMed: 14641005]
18. Ronnett GV, Kim EK, Landree LE, Tu Y. Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005 May 19;85(1):25-35. [PubMed: 15878185]
19. Brovko LYu, Romanova NA, Ugarova NN. Bioluminescent assay of bacterial intracellular AMP, ADP, and ATP with the use of a coimmobilized three-enzyme reagent (adenylate kinase, pyruvate kinase, and firefly luciferase). Anal Biochem. 1994 Aug 01;220(2):410-4. [PubMed: 7978286]
20. Hayashida M, Fukuda K, Fukunaga A. Clinical application of adenosine and ATP for pain control. J Anesth. 2005;19(3):225-35. [PubMed: 16032451]
21. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs. 1999 Aug;58(2):211-32. [PubMed: 10473017]

Disclosures: Jacob Dunn declares no relevant financial relationships with ineligible companies.

Disclosures: Michael Grider declares no relevant financial relationships with ineligible companies.